Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Valeant buys Instituto Terapeutico Delta for $28mm

Executive Summary

Valeant Pharmaceuticals International (mainly dermatology and neurology therapeutics) has agreed to pay $28mm for Instituto Terapeutico Delta Ltda., a private branded generics and OTC Brazilian company that has a portfolio of mostly dermatology drugs.
Deal Industry
  • Pharmaceuticals
    • Generic Drugs
    • OTC, Consumer
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Payment Includes Cash

Related Companies

Advertisement
UsernamePublicRestriction

Register